WASHINGTON, May 7, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the first quarter ended March 31, 2025.

Review which funds and institutions currently hold Vanda Pharmaceuticals Inc (VNDA:XNAS) stock for ownership information.

Legend Biotech (LEGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price ...

Review quarterly and annual revenue, net income, and cash flow for Vanda Pharmaceuticals Inc (VNDA:XNAS) stock through the last fiscal year.

AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find out why ANAB stock is a hold.

The cannabinoid agonist market is gaining momentum due to expanding medical cannabis legalization and growing clinical validation for its use in chro ...

Vanda Pharmaceuticals Inc. Annual stock financials by MarketWatch. View the latest VNDA financial statements, income statements and financial ratios.

Background: Subclinical hypothyroidism has been linked to adverse renal outcomes, but it is unknown whether treatment of subclinical hypothyroidism reduces the risk of these adverse outcomes. We ...

LEO is claiming global commercial rights to Spevigo for GPP, but will also collaborate with Boehringer on potential follow-up IL-36 mediated skin diseases, such as palmoplantar pustulosis and ...

"Theratechnologies shares surge 25% amid $254m Future Pak takeover" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

But they are also “clever maneuvering” from China, according to Vanda Felbab-Brown ... fentanyl makers would look to other countries with large pharmaceuticals and chemicals industries, such as India.